Mereo BioPharma Group plc Holding(s) in Company (7478D)
April 28 2017 - 10:37AM
UK Regulatory
TIDMMPH
RNS Number : 7478D
Mereo BioPharma Group plc
28 April 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
----------------------------------------------------------------------------------------
1. Identity of the issuer or Mereo BioPharma Group plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------- ---------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
----------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
------------------------------------------------------------ --------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------ --------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------ --------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------ --------------------------
Other (please
specify):
---------------------------------------------------------- --------------------------
3. Full name of person(s) Novartis Pharma AG
subject to the
notification obligation:
(iii)
----------------------------------------------------------- ---------------------------
4. Full name of shareholder(s)
(if different from 3.):(iv)
----------------------------------------------------------- ---------------------------
5. Date of the transaction 27 April 2017
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- ---------------------------
6. Date on which issuer 27 April 2017
notified:
----------------------------------------------------------- ---------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 19%
----------------------------------------------------------- ---------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- ----------------------------------- ------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
------------- ---------------- ----------------- -------------- ----------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ------------ ------------- -------------- --------- ------------ ------------ -----------
Ordinary
shares
of GBP0.03
each
GB00BZ4G2K23 12,546,480 18.1% 13,767,841 19.5%
---------------- ----------------- -------------- --------- ------------ ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- -------------- --------------------------------- ------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------------- -------------- --------------- ---------------- ------------------------- -----------------------
Nominal Delta
--------------- -------------- --------------- ---------------- ------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
---------------------------------------------------- ----------------------------------------------------------------
13,767,841 19.5%
---------------------------------------------------- ----------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
---------------------------------------------------------------------------------
Proxy Voting:
---------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- ------------------
11. Number of voting rights proxy
holder will cease to hold:
------------------------------------------------------------- ------------------
12. Date on which proxy holder will
cease to hold voting rights:
------------------------------------------------------------- ------------------
13. Additional information:
------------------------------------------------------------- ------------------
14. Contact name: Marc Ceulemans
------------------------------------------------------------- ------------------
15. Contact telephone number: 00 41 61 324 5365
------------------------------------------------------------- ------------------
Note: Annex should only be submitted to the FCA not
the issuer
Annex: Notification of major interests in share
A: Identity of the persons or legal entity subject to
the notification obligation
--------------------------------------------------------
Full name
(including legal form of
legal entities)
------------------------------------------------------
Contact address
(registered office for legal
entities)
------------------------------------------------------
Phone number & email
------------------------------------------------------
Other useful information
(at least legal representative
for legal persons)
------------------------------------------------------
B: Identity of the notifier, if applicable
--------------------------------------------------------
Full name
------------------------------------------------------
Contact address
------------------------------------------------------
Phone number & email
------------------------------------------------------
Other useful information
(e.g. functional relationship
with the person or legal
entity subject to the notification
obligation)
------------------------------------------------------
C: Additional information
--------------------------------------------------------
For notes on how to complete form TR-1 please see the
FCA website.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLIPMITMBJTBIR
(END) Dow Jones Newswires
April 28, 2017 10:37 ET (14:37 GMT)
Mereo Biopharma (LSE:MPH)
Historical Stock Chart
From Apr 2024 to May 2024
Mereo Biopharma (LSE:MPH)
Historical Stock Chart
From May 2023 to May 2024